- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
- Profile
- Financials
Akari Therapeutics (AKTX)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.54 mm | 2.54 mm | 2.54 mm | 2.54 mm | 2.54 mm | 2.54 mm |
| Cash burn (monthly) | 75.67 k | (no burn) | 2.50 mm | 1.62 mm | 707.00 k | 804.25 k |
| Cash used (since last report) | 289.80 k | n/a | 9.56 mm | 6.19 mm | 2.71 mm | 3.08 mm |
| Cash remaining | 2.25 mm | n/a | -7.02 mm | -3.65 mm | -163.74 k | -536.20 k |
| Runway (months of cash) | 29.8 | n/a | -2.8 | -2.3 | -0.2 | -0.7 |
| 13F holders | Current |
|---|---|
| Total holders | 7 |
| Opened positions | 1 |
| Closed positions | 5 |
| Increased positions | 1 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 1.82 bn |
| Total shares | 800.90 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| RPC Pharma | 800.77 mm | $1.44 bn |
| Omnia Family Wealth | 87.63 k | $258.50 mm |
| Cerity Partners | 23.64 k | $69.75 mm |
| Renaissance Technologies | 18.07 k | $53.30 mm |
| Advisor | 100.00 | $295.00 k |
| Truvestments Capital | 50.00 | $148.00 k |
| Cornerstone Planning | 5.00 | $13.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Dec 25 | Abizer Gaslightwala | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.4041 | 773,323 | 312.50 k | 773,323 |
| 16 Dec 25 | Abizer Gaslightwala | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.3883 | 773,323 | 300.28 k | 773,323 |
| 16 Dec 25 | Abizer Gaslightwala | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.4041 | 309,328 | 125.00 k | 309,328 |
| 16 Dec 25 | Abizer Gaslightwala | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.3883 | 309,328 | 120.11 k | 309,328 |
| 16 Dec 25 | Patel Samir Rashmikant | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | Yes | No | 0.4041 | 231,997 | 93.75 k | 231,997 |
| 16 Dec 25 | Patel Samir Rashmikant | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | Yes | No | 0.3883 | 231,997 | 90.08 k | 231,997 |
| 16 Dec 25 | Patel Samir Rashmikant | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.4041 | 618,658 | 250.00 k | 618,658 |
| 16 Dec 25 | Patel Samir Rashmikant | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.3883 | 618,658 | 240.22 k | 618,658 |
| 16 Dec 25 | Bazemore Robert B | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.4041 | 30,932 | 12.50 k | 30,932 |
| 16 Dec 25 | Bazemore Robert B | American Depositary Shares representing Ordinary Shares | Buy | Acquire P | No | No | 0.3883 | 30,932 | 12.01 k | 30,932 |